Publication | Open Access

Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial

InflammationLong-term EffectAutoimmune DiseaseVasculitisImmunologyPathologyGiant Cell ArteritisMedicineOpen-label Extension Phase